Question explored with the scientific record
what are the side effects of metformin?
Metformin’s main side effects are gut problems and a slow drain of vitamin B12, with a rare but real risk of lactic acidosis when kidneys are weak.
The most common side effects hit the stomach. In one study of people with metformin gut trouble, heartburn was the most frequent complaint, reported by about 54 in 100 [1]. Nausea, diarrhea, and abdominal pain are the classic trio, usually manageable by lowering the dose [2]. Women appear more sensitive: one study found females had roughly 3.8 times the odds of gut intolerance compared to men [1]. A meta-analysis in type 1 diabetes found metformin roughly doubled the relative risk of gastrointestinal adverse events [3].
The quieter problem is vitamin B12. Long-term use steadily lowers B12 levels, with deficiency reported in anywhere from about 6 to 35 in 100 patients depending on the study [8]. One large analysis put the odds of deficiency at about 2.5 times higher with metformin [9]. Higher doses and longer use make it worse [11][13]. This matters because B12 deficiency can mimic or worsen diabetic nerve damage [10][12]. A 2026 Ugandan study found B12 deficiency in about 10 in 100 metformin users, and it was linked to more neuropathy [13].
Lactic acidosis is the feared complication, but it is rare and heavily concentrated in people with kidney problems. A large 2018 study found the risk only rose when kidney function (eGFR) dropped below 30 [4]. Case reports show it can be fatal, especially with missed dialysis or binge drinking [5][7]. One series of 16 patients with metformin-associated lactic acidosis reported a 31 in 100 death rate [6].
| Side effect | How common | Notes |
|---|---|---|
| Heartburn | ~54 in 100 with gut issues | Most common gut complaint [1] |
| Gut intolerance | Higher in women | ~3.8x odds vs men [1] |
| B12 deficiency | ~6–35 in 100 | Worse with dose and duration [8][11] |
| Lactic acidosis | Rare | Risk rises when eGFR <30 [4] |
The evidence base is decent for the gut effects and B12 depletion, but much of it is observational. The B12 data comes from many studies and is consistent. The lactic acidosis risk is well documented in case series and large cohorts, though the absolute rate in healthy kidneys is low.
My call: metformin reliably causes gut distress and B12 depletion, and the B12 loss is underappreciated; anyone on it long-term should have B12 checked. Confidence: high for gut effects and B12 depletion, moderate for the exact frequency of lactic acidosis.
Sources used 13
-
Influence of SLC22A1 gene polymorphisms on gastrointestinal adverse effects with metformin therapy in South Indian type 2 diabetes mellitus patients
In South Indian type 2 diabetes patients, SLC22A1 rs628031 was not associated with metformin gastrointestinal intolerance, female sex was associated with higher adjusted risk, and heartburn was the most common adverse effect.
DOI: 10.18203/2319-2003.ijbcp20240383 -
Insulin Resistance and the Cardiometabolic Syndrome in HIV Infection
Insulin resistance and cardiometabolic syndrome are common complications of HIV infection treated with HAART, linked to lipodystrophy and adipose tissue redistribution; management includes lifestyle changes and pharmacologic therapy (e.g., metformin) with caution for lactic acid…
DOI: 10.1111/j.1559-4572.2008.00027.x -
Efficacy and Safety of Metformin for Patients with Type 1 Diabetes Mellitus: A Meta-Analysis
A meta-analysis of eight randomized controlled trials (n=300) in type 1 diabetes mellitus found that adding metformin to insulin reduces daily insulin dosage, body weight, and some lipid measures but does not improve HbA1c or fasting glucose and increases the risk of gastrointes…
DOI: 10.1089/dia.2014.0190 -
Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function
This study investigates the association between metformin use and the risk of lactic acidosis in patients with varying levels of kidney function, finding that metformin is associated with increased risk only in patients with an estimated glomerular filtration rate (eGFR) less th…
DOI: 10.1001/jamainternmed.2018.0292 -
Occult Metformin Toxicity in Three Patients with Profound Lactic Acidosis
This study presents three cases of metformin toxicity leading to profound lactic acidosis, highlighting the risks associated with metformin use in patients with renal insufficiency and the challenges in diagnosing and managing such cases in the emergency department.
DOI: 10.1016/j.jemermed.2007.11.055 -
Metformin associated lactic acidosis (MALA): clinical profiling and management
This study profiles 16 patients with metformin-associated lactic acidosis (MALA), highlighting the clinical characteristics, treatment outcomes, and the significant mortality risk associated with this condition, particularly in patients with chronic kidney disease.
DOI: 10.1007/s40620-016-0267-8 -
Metformin and alcohol binge drinking: a dangerous synergy
A case report of a 52-year-old man with recurrent alcoholic ketoacidosis and metformin-associated lactic acidosis after binge drinking, illustrating diagnostic confusion with diabetic ketoacidosis and the synergistic risk of metformin toxicity in alcohol use.
DOI: 10.15277/bjd.2025.476 -
Metformin and vitamin B12 deficiency: What is the evidence?
This meta-analysis review found that metformin use is associated with decreased vitamin B12 concentrations and a higher prevalence of vitamin B12 deficiency than stated in regulatory product characteristics, with reductions from 6.3% to 35%.
DOI: 10.5937/scriptamed55-48795 -
The role of metformin on vitamin B12 deficiency: a meta-analysis review
This meta-analysis review investigates the association between metformin treatment and vitamin B12 deficiency, concluding that metformin significantly increases the incidence of B12 deficiency and reduces serum B12 levels in patients with type 2 diabetes mellitus.
DOI: 10.1007/s11739-014-1157-5 -
ROLE OF VITAMIN B12 SUPPLEMENTATION IN METFORMIN INDUCED DIABETIC NEUROPATHY IN INDIAN PATIENTS. CAN SUPPLEMENTATION HELP?
The paper concludes that type 2 diabetes patients on long-term metformin may have silent vitamin B12 deficiency that may add to neuropathy, and describes a study of vitamin B12 supplementation with VPT measurement in Indian patients.
DOI: 10.32553/ijmbs.v3i11.743 -
Vitamin B 12 deficiency in type 2 diabetic patients on metformin: a cross-sectional study from South-Western part of Ghana
A cross-sectional study in Ghanaian type 2 diabetics on metformin to determine the prevalence of vitamin B12 deficiency using serum B12 and methylmalonic acid (MMA) measurements and to identify associated risk factors such as metformin dose, duration, and body fat.
DOI: 10.1080/20905068.2019.1662647 -
Effect of Vitamin B12 supplementation on the Diabetic Peripheral Neuropathy- a Review
This narrative review concludes that long-term metformin use is linked to vitamin B12 deficiency, elevated methylmalonic acid, and a higher occurrence of diabetic neuropathy, while B12 supplementation may be beneficial and is reported without adverse effects.
DOI: 10.32350/ihr.21.05 -
Evaluation of Vitamin B12 Deficiency Among Patients with Type 2 Diabetes Mellitus on Metformin at Hoima Regional Referral Hospital, Uganda
Among Ugandan adults with type 2 diabetes on metformin at Hoima Regional Referral Hospital, vitamin B12 deficiency occurred in 10.1% and was independently linked to higher metformin dose (2000 mg/day), longer duration of therapy (≥10 years), and poor glycemic control, with defic…
DOI: 10.2147/DMSO.S562440